Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder

Koichiro Wasano, Tatsuo Matsunaga, Kaoru Ogawa, Shinji Kunishima

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

MYH9 disorder is a rare autosomal-dominant disorder. We previously reported that it is caused by mutations in the gene for nonmuscle myosin heavy chain IIA (NMMHC-IIA). MYH9 disorder causes congenital macrothrombocytopenia accompanied by progressive sensorineural hearing loss, nephropathy, and cataract. However, there are few reports that describe the audiological features of MYH9 disorder. The objective of this study was to characterize auditory and other phenotypes of patients with MYH9 disorder. We examined nine subjects from one Japanese family. Audiological, ophthalmological, hematological, and imaging examinations were used to assess clinical features. We carried out genetic analysis of the causative gene, MYH9. Five subjects exhibited macrothrombocytopenia and neutrophil cytoplasmic inclusion bodies. Immunofluorescence analysis of neutrophil NMMHC-IIA revealed abnormal type II localization. Two subjects had high-frequency dominant hearing loss, which was adult onset and progressive. Only one subject had cataract. MYH9 sequencing analysis of all thrombocytopenic subjects revealed a heterozygous c.4270G>A mutation in exon 30 (p.D1424N). We identified five patients with MYH9 disorder from the family. The hearing impairment associated with MYH9 disorder in this family was characterized as adult onset, progressive, and high-frequency dominant. Hematological manifestations of MYH9 disorder show complete penetrance, whereas extra-hematological manifestations show incomplete penetrance and variable expressivity in this family.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalEuropean Archives of Oto-Rhino-Laryngology
DOIs
Publication statusAccepted/In press - 2016 Mar 4

Fingerprint

High-Frequency Hearing Loss
Myosin Heavy Chains
Penetrance
Inclusion Bodies
Cataract
Neutrophils
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mutation
Sensorineural Hearing Loss
Hearing Loss
Genes
Fluorescent Antibody Technique
Exons
Phenotype

Keywords

  • Cataract
  • Macrothrombocytopenia
  • MYH9 disorder
  • Nephropathy
  • Sensorineural hearing loss
  • Variable expressivity

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder. / Wasano, Koichiro; Matsunaga, Tatsuo; Ogawa, Kaoru; Kunishima, Shinji.

In: European Archives of Oto-Rhino-Laryngology, 04.03.2016, p. 1-6.

Research output: Contribution to journalArticle

@article{4b53a4df8972416d8df96f85e62cc7fb,
title = "Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder",
abstract = "MYH9 disorder is a rare autosomal-dominant disorder. We previously reported that it is caused by mutations in the gene for nonmuscle myosin heavy chain IIA (NMMHC-IIA). MYH9 disorder causes congenital macrothrombocytopenia accompanied by progressive sensorineural hearing loss, nephropathy, and cataract. However, there are few reports that describe the audiological features of MYH9 disorder. The objective of this study was to characterize auditory and other phenotypes of patients with MYH9 disorder. We examined nine subjects from one Japanese family. Audiological, ophthalmological, hematological, and imaging examinations were used to assess clinical features. We carried out genetic analysis of the causative gene, MYH9. Five subjects exhibited macrothrombocytopenia and neutrophil cytoplasmic inclusion bodies. Immunofluorescence analysis of neutrophil NMMHC-IIA revealed abnormal type II localization. Two subjects had high-frequency dominant hearing loss, which was adult onset and progressive. Only one subject had cataract. MYH9 sequencing analysis of all thrombocytopenic subjects revealed a heterozygous c.4270G>A mutation in exon 30 (p.D1424N). We identified five patients with MYH9 disorder from the family. The hearing impairment associated with MYH9 disorder in this family was characterized as adult onset, progressive, and high-frequency dominant. Hematological manifestations of MYH9 disorder show complete penetrance, whereas extra-hematological manifestations show incomplete penetrance and variable expressivity in this family.",
keywords = "Cataract, Macrothrombocytopenia, MYH9 disorder, Nephropathy, Sensorineural hearing loss, Variable expressivity",
author = "Koichiro Wasano and Tatsuo Matsunaga and Kaoru Ogawa and Shinji Kunishima",
year = "2016",
month = "3",
day = "4",
doi = "10.1007/s00405-016-3954-0",
language = "English",
pages = "1--6",
journal = "European Archives of Oto-Rhino-Laryngology",
issn = "0937-4477",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder

AU - Wasano, Koichiro

AU - Matsunaga, Tatsuo

AU - Ogawa, Kaoru

AU - Kunishima, Shinji

PY - 2016/3/4

Y1 - 2016/3/4

N2 - MYH9 disorder is a rare autosomal-dominant disorder. We previously reported that it is caused by mutations in the gene for nonmuscle myosin heavy chain IIA (NMMHC-IIA). MYH9 disorder causes congenital macrothrombocytopenia accompanied by progressive sensorineural hearing loss, nephropathy, and cataract. However, there are few reports that describe the audiological features of MYH9 disorder. The objective of this study was to characterize auditory and other phenotypes of patients with MYH9 disorder. We examined nine subjects from one Japanese family. Audiological, ophthalmological, hematological, and imaging examinations were used to assess clinical features. We carried out genetic analysis of the causative gene, MYH9. Five subjects exhibited macrothrombocytopenia and neutrophil cytoplasmic inclusion bodies. Immunofluorescence analysis of neutrophil NMMHC-IIA revealed abnormal type II localization. Two subjects had high-frequency dominant hearing loss, which was adult onset and progressive. Only one subject had cataract. MYH9 sequencing analysis of all thrombocytopenic subjects revealed a heterozygous c.4270G>A mutation in exon 30 (p.D1424N). We identified five patients with MYH9 disorder from the family. The hearing impairment associated with MYH9 disorder in this family was characterized as adult onset, progressive, and high-frequency dominant. Hematological manifestations of MYH9 disorder show complete penetrance, whereas extra-hematological manifestations show incomplete penetrance and variable expressivity in this family.

AB - MYH9 disorder is a rare autosomal-dominant disorder. We previously reported that it is caused by mutations in the gene for nonmuscle myosin heavy chain IIA (NMMHC-IIA). MYH9 disorder causes congenital macrothrombocytopenia accompanied by progressive sensorineural hearing loss, nephropathy, and cataract. However, there are few reports that describe the audiological features of MYH9 disorder. The objective of this study was to characterize auditory and other phenotypes of patients with MYH9 disorder. We examined nine subjects from one Japanese family. Audiological, ophthalmological, hematological, and imaging examinations were used to assess clinical features. We carried out genetic analysis of the causative gene, MYH9. Five subjects exhibited macrothrombocytopenia and neutrophil cytoplasmic inclusion bodies. Immunofluorescence analysis of neutrophil NMMHC-IIA revealed abnormal type II localization. Two subjects had high-frequency dominant hearing loss, which was adult onset and progressive. Only one subject had cataract. MYH9 sequencing analysis of all thrombocytopenic subjects revealed a heterozygous c.4270G>A mutation in exon 30 (p.D1424N). We identified five patients with MYH9 disorder from the family. The hearing impairment associated with MYH9 disorder in this family was characterized as adult onset, progressive, and high-frequency dominant. Hematological manifestations of MYH9 disorder show complete penetrance, whereas extra-hematological manifestations show incomplete penetrance and variable expressivity in this family.

KW - Cataract

KW - Macrothrombocytopenia

KW - MYH9 disorder

KW - Nephropathy

KW - Sensorineural hearing loss

KW - Variable expressivity

UR - http://www.scopus.com/inward/record.url?scp=84960113794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960113794&partnerID=8YFLogxK

U2 - 10.1007/s00405-016-3954-0

DO - 10.1007/s00405-016-3954-0

M3 - Article

C2 - 26942920

AN - SCOPUS:84960113794

SP - 1

EP - 6

JO - European Archives of Oto-Rhino-Laryngology

JF - European Archives of Oto-Rhino-Laryngology

SN - 0937-4477

ER -